DE2510926C3 - 4'-epi-Daunomycuie, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen - Google Patents

4'-epi-Daunomycuie, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE2510926C3
DE2510926C3 DE2510926A DE2510926A DE2510926C3 DE 2510926 C3 DE2510926 C3 DE 2510926C3 DE 2510926 A DE2510926 A DE 2510926A DE 2510926 A DE2510926 A DE 2510926A DE 2510926 C3 DE2510926 C3 DE 2510926C3
Authority
DE
Germany
Prior art keywords
epi
compounds
daunomycuie
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2510926A
Other languages
German (de)
English (en)
Other versions
DE2510926A1 (de
DE2510926B2 (de
Inventor
Federico Arcamone
Aurelio Dimarco
Sergio Penco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of DE2510926A1 publication Critical patent/DE2510926A1/de
Publication of DE2510926B2 publication Critical patent/DE2510926B2/de
Application granted granted Critical
Publication of DE2510926C3 publication Critical patent/DE2510926C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE2510926A 1974-03-20 1975-03-13 4'-epi-Daunomycuie, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Expired DE2510926C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1225474A GB1457559A (en) 1974-03-20 1974-03-20 Daunomycins

Publications (3)

Publication Number Publication Date
DE2510926A1 DE2510926A1 (de) 1975-09-25
DE2510926B2 DE2510926B2 (de) 1979-07-19
DE2510926C3 true DE2510926C3 (de) 1980-03-13

Family

ID=10001195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2510926A Expired DE2510926C3 (de) 1974-03-20 1975-03-13 4'-epi-Daunomycuie, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Country Status (13)

Country Link
JP (1) JPS5833880B2 (US08197722-20120612-C00093.png)
AT (1) AT338419B (US08197722-20120612-C00093.png)
BE (1) BE826848A (US08197722-20120612-C00093.png)
CA (1) CA1046508A (US08197722-20120612-C00093.png)
CH (1) CH615198A5 (US08197722-20120612-C00093.png)
DE (1) DE2510926C3 (US08197722-20120612-C00093.png)
DK (1) DK146541C (US08197722-20120612-C00093.png)
FR (1) FR2264554B1 (US08197722-20120612-C00093.png)
GB (1) GB1457559A (US08197722-20120612-C00093.png)
NL (1) NL176636C (US08197722-20120612-C00093.png)
SE (1) SE434843B (US08197722-20120612-C00093.png)
SU (1) SU589926A3 (US08197722-20120612-C00093.png)
ZA (1) ZA751687B (US08197722-20120612-C00093.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
FR2678274A1 (fr) * 1991-06-25 1992-12-31 Medgenix Group Sa N-leucyl epirubicine application a titre de medicament antitumoral et procede de preparation.

Also Published As

Publication number Publication date
GB1457559A (en) 1976-12-08
SE7503084L (US08197722-20120612-C00093.png) 1975-09-22
ATA202875A (de) 1976-12-15
AU7919775A (en) 1976-09-23
DK109275A (US08197722-20120612-C00093.png) 1975-09-21
CA1046508A (en) 1979-01-16
DE2510926A1 (de) 1975-09-25
DK146541B (da) 1983-10-31
SU589926A3 (ru) 1978-01-25
SE434843B (sv) 1984-08-20
FR2264554B1 (US08197722-20120612-C00093.png) 1978-07-28
NL176636C (nl) 1985-05-17
NL176636B (nl) 1984-12-17
BE826848A (fr) 1975-09-19
JPS5833880B2 (ja) 1983-07-22
DE2510926B2 (de) 1979-07-19
AT338419B (de) 1977-08-25
SE7503084A (US08197722-20120612-C00093.png) 1975-09-22
DK146541C (da) 1984-04-09
NL7503079A (nl) 1975-09-23
JPS50126657A (US08197722-20120612-C00093.png) 1975-10-04
FR2264554A1 (US08197722-20120612-C00093.png) 1975-10-17
ZA751687B (en) 1976-02-25
CH615198A5 (en) 1980-01-15

Similar Documents

Publication Publication Date Title
DE2510866C3 (de) 4'-epi-Adriamycin a - und ß -Anomer, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2525633C3 (US08197722-20120612-C00093.png)
DE2618822C3 (de) Anthracyclin-Glycoside und Verfahren zu deren Herstellung
DE3214559C2 (de) 4'-Desoxy-4'-iod-daunorubicin und -doxorubicin und diese Verbindungen enthaltende Arzneimittel
DE3044740A1 (de) Nucleosidderivate, ihre herstellung und pharmazeutische mittel
EP0270992A2 (de) Zytostatisch wirksame Anthracyclinderivate
DE69312729T2 (de) Antiproliferative und entzündungshemmende verbindungen. pentose monosaccharid-derivate
DE60005300T2 (de) 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion-inhibitoren
DE2510926C3 (de) 4'-epi-Daunomycuie, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE1811518C3 (de) Daunonibicinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2757102C2 (de) Anthracyclinglycoside, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE3508356C2 (US08197722-20120612-C00093.png)
EP0286926B1 (de) Semisynthetische Rhodomycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Zytostatika
DE2735455C3 (de) Daunomycinanaloga, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3028148A1 (de) N-glykosylderivate der antibiotika aus der anthracylingruppe, verfahren zu deren herstellung und arzneimittel
DE69029781T2 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
DE2366288C3 (de) Verfahren zur Herstellung von 3' -Desoxykanamycin B und 3' -Desoxyneamin
DE2618009A1 (de) 1-n-(alpha-hydroxy-omega-aminoacyl)-derivate des 3'-deoxykanamycins a und verfahren zur herstellung derselben
DE2517293C2 (de) Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung
CH660740A5 (de) Halogenanthracyclinglykoside.
DE3317702C2 (US08197722-20120612-C00093.png)
DE2942818A1 (de) Neue antitumoranthracycline mit einem gehalt an verzweigtkettigen aminodeoxyzuckern und verfahren zu deren herstellung
EP0277310A1 (de) Zytostatisch wirksame Anthracyclinderivate
DE2846383C3 (de) l-(2-Chloräthyl)-l-nitroso-3-(D-ribofuranosyl)-harnstoffe, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
AT381098B (de) Verfahren zur herstellung von anthracyclinglykosiden

Legal Events

Date Code Title Description
OD Request for examination
C3 Grant after two publication steps (3rd publication)